Peritoneal Carcinomatosis clinical trials

Explore recruiting peritoneal carcinomatosis clinical trials.

Recruiting peritoneal carcinomatosis studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Peritoneal Carcinomatosis trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

Treatment of peritoneal dissemination in stomach cancer patients with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy; PERISCOPE-2

Sweden, Finland, Denmark, Netherlands

Therapeutic exploratory (Phase II) EU CTIS Study details

A Phase 2, randomised, open label, multicentre study to evaluate efficacy and safety of an intraperitoneal α-emitting radionuclide therapy (Radspherin®) in patients with peritoneal carcinomatosis from colorectal carcinoma following cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC)

Netherlands, Norway, Sweden

Therapeutic exploratory (Phase II) EU CTIS Study details

A Phase 2, randomised, open label, multicentre study of an intraperitoneal α-emitting radionuclide therapy (Radspherin®) in patients with primary advanced high-grade serous or high-grade endometrioid epithelial ovarian, fallopian tube, or primary peritoneal cancer, with peritoneal metastasis that are homologous recombination proficient and scheduled to undergo neoadjuvant chemotherapy and interval debulking surgery

Belgium, Norway, Spain, Italy

Therapeutic exploratory (Phase II) EU CTIS Study details

Randomised Phase III Trial of First Line Intraperitoneal Paclitaxel and Systemic Therapy versus Systemic Therapy Alone in Gastric Cancer Patients with Peritoneal Metastases

Italy, Sweden, Netherlands, Norway

Therapeutic confirmatory (Phase III) EU CTIS Study details

Intraperitoneal Aerosolized Nanoliposomal Irinotecan (Nal-IRI) in Peritoneal Carcinomatosis from Gastrointestinal cancer: a phase I study.

Belgium

Human Pharmacology (Phase I)- Other EU CTIS Study details

A phase 1/2a study to evaluate the dose, safety, tolerability, and efficacy of an intraperitoneal α-emitting radionuclide therapy (Radspherin®) in subjects with peritoneal carcinomatosis from colorectal carcinoma following hyperthermic intraperitoneal chemotherapy

Sweden, Norway

Human Pharmacology (Phase I)- First administration to humans EU CTIS Study details

Peritoneal Carcinomatosis trials by city

Peritoneal Carcinomatosis in Toronto Peritoneal Carcinomatosis in Vancouver Peritoneal Carcinomatosis in Montreal Peritoneal Carcinomatosis in Calgary Peritoneal Carcinomatosis in Edmonton Peritoneal Carcinomatosis in Ottawa Peritoneal Carcinomatosis in Winnipeg Peritoneal Carcinomatosis in Quebec City Peritoneal Carcinomatosis in Hamilton Peritoneal Carcinomatosis in Kitchener Peritoneal Carcinomatosis in London Peritoneal Carcinomatosis in Halifax Peritoneal Carcinomatosis in New York Peritoneal Carcinomatosis in Los Angeles Peritoneal Carcinomatosis in Chicago Peritoneal Carcinomatosis in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease